Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-17
2007-04-17
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S469000
Reexamination Certificate
active
11183626
ABSTRACT:
Modulators of the CRTH2 receptor and their use in the treatment of various disorders, including asthma are described.
REFERENCES:
patent: 3629284 (1971-12-01), Yamamoto
patent: 5990150 (1999-11-01), Matsui et al.
patent: 6262098 (2001-07-01), Huebner et al.
patent: 6291505 (2001-09-01), Huebner et al.
patent: 0620214 (1999-03-01), None
patent: 1170594 (2002-01-01), None
patent: 2407318 (2005-04-01), None
patent: WO 00/51685 (2000-09-01), None
patent: WO 01/06537 (2001-01-01), None
patent: WO 03/066046 (2003-08-01), None
Maguire et al. Bioorganic & Medicinal Chemistry, (2001), 9(3), p. 745-762.
STN seatch report and abstract, EP620214 Bach et al. (1994).
STN search report: U.S. Patent 6,684,034 and 6,252,084 (Bach et al.).
Cali Brian M.
Chen Barbara
Chien Yueh-Tyng
Currie Mark G.
Milne G. Todd
Chu Yong
Microbia, Inc.
Saeed Kamal A.
LandOfFree
Modulators of CRTH2 activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of CRTH2 activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of CRTH2 activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3793837